New research reveals that individuals who discontinue popular GLP-1 drugs like Wegovy and Mounjaro may regain shed pounds much more quickly than those who stop traditional lifestyle plans.
Published data in a leading health publication demonstrates that while overweight people frequently drop about a fifth of their total mass while using the jabs, the weight is regained at an average rate of 0.8 kg per month once they quit.
"Users using these treatments need to be cognizant of the potential of quick rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.
This pace of recovery suggests a return to pre-treatment mass in about a year and a half.
Analyzing Approaches
The research, which examined dozens of studies involving thousands of participants, compared the results of the injectable medications with conventional dieting.
The team emphasize that individuals who shed pounds through dieting generally experience a less rapid weight regain—perhaps 0.1 kg a month—post-intervention.
Explaining the Fast Regain
Doctors suggest the mode of action of the injections explains the amplified regain.
GLP-1 drugs mimic a natural hormone called GLP-1, which moderates hunger.
"Sustained high doses of GLP-1 concentrations several times higher than normal may cause the body to generate a reduced amount of its endogenous GLP-1, and may also reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this hormone supplement results in appetite is no longer kept in check, making overeating far more likely."
An Ongoing Condition?
The NHS advise the jabs for people with obesity-related health risks, alongside prescribed diet and exercise modifications.
Professionals contend that, due to the high risk of relapse, the treatment might need to be ongoing.
This view is supported by drug manufacturers, who state that the results "underscore the long-term character of excess weight," similar to managing conditions like diabetes.
User Accounts
Users who have stopped the jabs explain a sudden return of hunger.
"I experienced something that goes on and I was suddenly ravenous," said a patient.
This challenge is compounded if patients have not developed sustainable lifestyle or habit modifications during therapy.
Significant Use
Figures show that millions of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Use is more common among females than males.
- The 40s and 50s age group shows the greatest usage rates.
- Many access the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while the jabs are potent agents for weight loss, they are not a magic fix and lasting health benefits relies on combined lifestyle management.
